FrancophonIA/ELRC3.0 huggingface dataset:
English: There is no need to protect healthy untreated skin.
Croatian: Okolnu zdravu neliječenu kožu nije potrebno zaštititi.
English: Subsequently, close long term clinical monitoring of BCC is recommended, with histology if necessary.
Croatian: Nakon toga se preporučuje dugotrajno, pažljivo kliničko praćenje bazocelularnog karcinoma, s patohistologijom po potrebi.
English: Symptomatic treatment of transient adverse site reactions may be considered.
Croatian: Može se razmotriti simptomatsko liječenje prolaznih nuspojava na mjestu primjene.
English: Field cancerization is characterised by an area of skin where multiple AK lesions are present and there is likely to be an underlying and surrounding area of actinic damage (a concept known as field cancerization or field change); the extent of this area may not be evident visually or by physical examination.
Croatian: Područna zloćudna transformacija karakterizirana je područjem kože na kojem je prisutno više lezija aktiničke keratoze ispod i oko kojih vjerojatno postoji područje aktiničkog oštećenja (pojam poznat kao područna zloćudna transformacija ili područna promjena); veličina ovog područja ne može se uvijek odrediti vizualnim ili fizikalnim pregledom.
English: 51377 Leverkusen Germany
Croatian: 51377 Leverkusen
English: In case of accidental contact, the site must be rinsed with water.
Croatian: U slučaju nehotičnog dodira, to se mjesto mora isprati vodom.
English: No experience exists for the use of Ameluz in patients with inherited or acquired coagulation defects.
Croatian: Nema iskustva s primjenom lijeka Ameluz u bolesnika s naslijeđenim ili stečenim defektima u koagulaciji.
English: In a third randomised, double-blind clinical trial, enrolling 87 patients, Ameluz and placebo were compared on entire treatment fields (field cancerization) containing 4 to 8 AK lesions in a field area of maximum 20 cm2.
Croatian: U trećem randomiziranom, dvostruko slijepom kliničkom ispitivanju koje je uključilo 87 bolesnika, Ameluz i placebo bili su uspoređeni na cjelovitim liječenim područjima (područjima zloćudne transformacije) na kojima je bilo 4 do 8 lezija aktiničke keratoze na površini veličine maksimalno 20 cm2.
English: Ameluz is only used on the skin.
Croatian: Kako primjenjivati Ameluz Ameluz se primjenjuje samo na kožu.
English: One gram gel contains 2.4 mg sodium benzoate (E211), 3 mg soybean phosphatidylcholine, and 10 mg propylene glycol.
Croatian: Jedan gram gela sadrži 2,4 mg natrijevog benzoata (E211), 3 mg sojinog fosfatidilkolina i 10 mg propilenglikola.
English: Ameluz was also compared with placebo treatment in a randomised, double-blind clinical trial enrolling 122 AK patients.
Croatian: Ameluz je također uspoređen s placebo liječenjem u randomiziranom, dvostruko slijepom kliničkom ispitivanju s uključenih 122 bolesnika s aktiničkom keratozom.
English: • Avoid sun exposure on the treated lesion sites and surrounding skin for approximately 48 hours following treatment.
Croatian: • Izbjegavajte izlaganje suncu liječenih mjesta lezija i okolne kože tijekom približno 48 sati nakon liječenja.
English: Corresponding studies in human skin with actinic keratosis lesions and/or roughened surface were not performed.
Croatian: Nisu provedena odgovarajuća ispitivanja na ljudskoj koži s lezijama aktiničke keratoze i/ili hrapavom površinom.
English: Direct contact of Ameluz with the eyes or mucous membrane should be avoided.
Croatian: Izravni kontakt lijeka Ameluz s očima ili sluznicama treba izbjegavati.
English: During the post-marketing phase 20 cases indicative of application site hypersensitivity have been received for Ameluz.
Croatian: Tijekom razdoblja nakon stavljanja lijeka u promet primljeno je 20 slučajeva indikativnih za preosjetljivost na mjestu primjene lijeka Ameluz.
English: As a general precaution, sun exposure on the treated lesion sites and surrounding skin should be avoided for approximately 48 hours following treatment.
Croatian: Kao opća mjera opreza, treba izbjegavati izlaganje suncu liječenih lezija i okolne kože tijekom približno 48 sati nakon liječenja.
English: The side effects listed below have been reported when using Ameluz with a red-light lamp.
Croatian: Niže navedene nuspojave prijavljene su kad se Ameluz primjenjivao uz crvenu svjetlost iz lampe.
English: Actinic keratosis lesions or fields shall be evaluated three months after treatment.
Croatian: Lezije ili područja aktiničke keratoze ocjenjuju se tri mjeseca nakon liječenja.
English: The most common signs and symptoms are application site irritation, erythema, pain, and oedema.
Croatian: Najčešći znakovi i simptomi su nadraženost, eritem, bol i edem na mjestu primjene.
English: The treated lesions should be evaluated 3 months after treatment.
Croatian: Liječene lezije potrebno je ocijeniti 3 mjeseca nakon liječenja.
English: • propylene glycol: May cause skin irritation.
Croatian: • propilenglikol: Može nadražiti kožu.
English: Hyperpigmentation
Croatian: Hiperpigment acija
English: The incidence of adverse reactions in 574 subjects exposed to photodynamic therapy with Ameluz in pivotal clinical trials is listed below.
Croatian: Incidencija nuspojava u 574 ispitanika podvrgnuta fotodinamskoj terapiji s lijekom Ameluz u pivotalnim kliničkim ispitivanjima navedena je u nastavku.
English: How to use Ameluz
Croatian: Kako primjenjivati Ameluz
English: Type of skin impairment
Croatian: Vrsta oštećenja kože
English: BCC on the trunk (only)
Croatian: BCC (samo) na trupu
English: Intensity of adverse reactions, particularly pain, was lower when Ameluz was used in combination with daylight PDT.
Croatian: Intenzitet nuspojava, osobito bola, bio je manji kad se Ameluz primjenjivao u kombinaciji s fotodinamskom terapijom danjim svjetlom.
English: • slightly palpable to moderately thick actinic keratoses on the face and scalp or entire fields affected by actinic keratoses in adults.
Croatian: • malo opipljivih do umjereno debelih aktiničkih keratoza na licu i vlasištu ili cijelih područja zahvaćenih aktiničkim keratozama u odraslih uključujući starije osobe.
English: c) Illumination: Immediately after cleaning the lesions, the entire treatment area will be illuminated with a red light source, either with a narrow spectrum around 630 nm and a light dose of approximately 37 J/cm2 or a broader and continuous spectrum in the range between 570 and 670 nm with a light dose between 75 and 200 J/cm2.
Croatian: c) Osvjetljavanje: Odmah nakon čišćenja lezija, cijelo se područje liječenja osvjetljava izvorom crvene svjetlosti bilo uskog spektra oko 630 nm i dozom svjetlosti od približno 37 J/cm2 ili šireg i kontinuiranog spektra u rasponu od 570 i 670 nm s dozom svjetlosti 75 i 200 J/cm2.
English: A class waiver exists for basal cell carcinoma (see section 4.2 for information on paediatric use).
Croatian: Za ovu skupinu lijekova postoji izuzeće za bazocelularni karcinom (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: Total lesion clearance was higher for Ameluz (81.1%) compared to placebo (20.9%).
Croatian: Ukupno uklanjanje lezija bilo je više za Ameluz (81,1%) u usporedbi s placebom (20,9%).
English: There are no or limited amount of data (less than 300 pregnancy outcomes) from the use of 5-aminolaevulinic acid in pregnant women.
Croatian: Nema podataka ili su podaci o primjeni 5-aminolevulinatne kiseline u trudnica ograničeni (manje od 300 ishoda trudnoća).
English: After Ameluz treatment, 6.2% of the lesions were recurrent after 6 and additionally 2.9% after 12 months, respectively (placebo: 1.9% after 6 and additionally 0% after 12 months, respectively).
Croatian: Nakon liječenja lijekom Ameluz, 6,2% lezija vratilo se nakon 6 mjeseci te dodatnih 2,9% nakon 12 mjeseci (placebo: 1,9% nakon 6 i dodatnih 0% nakon 12 mjeseci).
English: Carcinogenicity studies have not been performed with ALA.
Croatian: Ispitivanja kancerogenosti nisu provedena s aminolevulinatnom kiselinom.
English: Cosmetic outcome assessed 12 weeks after the last photodynamic therapy (with baseline sum score 0 excluded) was judged as: very good or good in 43.1% of subjects in the Ameluz group, 45.2% in the MAL group and 36.4% in the placebo group; and unsatisfactory or impaired in 7.9%, 8.1% and 18.2% of subjects, respectively.
Croatian: Kozmetički ishod ocijenjen 12 tjedana nakon zadnjeg fotodinamskog liječenja (pri čemu je isključen početni rezultat sa sumom 0) bio vrednovan kao: vrlo dobar ili dobar u 43,1% ispitanika u skupini s lijekom Ameluz, 45,2% u skupini s MAL i 36,4% u placebo skupini; a nezadovoljavajući ili nevaljan u 7,9%, 8,1% odnosno 18,2% ispitanika.
English: • Basal cell carcinoma is treated with two sessions, with an interval of one week between sessions.
Croatian: • Bazocelularni karcinom liječi se u dva tretmana, uz interval od jednog tjedna između tretmana.
English: Efficacy and safety of Ameluz for the treatment of basal cell carcinoma (BCC) with a thickness of <2mm has been evaluated in 281 patients enrolled in a phase III clinical trial.
Croatian: Liječenje bazocelularnog karcinoma (BCC): Djelotvornost i sigurnost lijeka Ameluz u liječenju bazocelularnog karcinoma (BCC) debljine <2 mm procijenjena je u 281 bolesnika uključenog u kliničko ispitivanje faze III.
English: If the weather is rainy, or is likely to become so, daylight treatment should not be used.
Croatian: Ako je vrijeme kišno ili će vjerojatno kišiti, liječenje pod danjim svjetlom ne smije se primijeniti.
English: Breast-feeding should be interrupted for 12 hours after application of Ameluz.
Croatian: Dojenje treba prekinuti na 12 sati nakon nanošenja lijeka Ameluz.
English: Only use daylight treatment if the weather is suitable to stay comfortably outdoors for two hours (with temperatures > 10 °C).
Croatian: Liječenje pod danjim svjetlom primijenite samo ako je vrijeme pogodno da se vani može ugodno provesti dva sata (uz temperature > 10 °C).
English: If the weather is rainy, or is likely to become so, you should not use daylight treatment.
Croatian: Ako je vrijeme kišno ili će vjerojatno kišiti, liječenje pod danjim svjetlom ne smijete primijeniti.
English: Lesion recurrence rates after 6 and 12 months were 2.9% and 6.7%, respectively, for Ameluz, and 4.3% and 8.2% for MAL.
Croatian: Stope recidiva lezija nakon 6 i 12 mjeseci bile su 2,9% odnosno 6,7% za Ameluz te 4,3% odnosno 8,2% za kremu MAL.
English: Basal cell carcinoma lesions shall be evaluated three months after last treatment.
Croatian: Lezije bazocelularnog karcinoma ocjenjuju se tri mjeseca nakon zadnjeg liječenja.
English: Breast-feeding should be discontinued for 12 hours after treatment with Ameluz.
Croatian: Dojenje treba prekinuti tijekom 12 sati nakon liječenja lijekom Ameluz.
English: In a clinical trial designed to investigate the sensitization potential of ALA with 216 healthy subjects, 13 subjects (6%) developed allergic contact dermatitis after continuous exposure for 21 days with doses of ALA that were higher than doses normally used in the treatment of AK. Allergic contact dermatitis has not been observed under regular treatment conditions.
Croatian: (ALA) u 216 zdravih ispitanika, 13 ispitanika (6%) razvilo je alergijski kontaktni dermatitis nakon neprekidne izloženosti tijekom 21 dana dozama ALA koje su bile više od onih koje se normalno primjenjuju u liječenju aktiničke keratoze.
English: Treated lesions or fields that have not completely resolved after 3 months shall be retreated.
Croatian: Liječene lezije ili područja na kojima se promjene nisu potpuno povukle nakon 3 mjeseca potrebno je ponovno liječiti.
English: Daylight may not be sufficient for Ameluz daylight treatment during winter months in certain parts of Europe.
Croatian: Za liječenje lijekom Ameluz pod danjim svjetlom tijekom zimskih mjeseci u određenim dijelovima Europe neće biti dovoljno danjeg svjetla.
English: N MAL Mean + SD (%)
Croatian: ALA srednja vrijednost + SD (%)
English: b) Preparation of the lesions: Sunscreen should be applied 15 min prior to lesion pretreatment in order to protect sun exposed skin.
Croatian: b) Priprema lezija: Preparat za zaštitu od sunca treba nanijeti 15 minuta prije predtretmana lezija radi zaštite kože izložene suncu.
English: There is no relevant use of Ameluz in the paediatric population.
Croatian: Pedijatrijska populacija Nema relevantne primjene lijeka Ameluz u pedijatrijskoj populaciji.
English: Interruption of the time outdoors should be compensated by a longer illumination time.
Croatian: Prekid razdoblja provedenog vani treba kompenzirati duljim vremenom osvjetljavanja.
English: Daylight PDT was performed outdoors for 2 continuous hours in full daylight.
Croatian: Fotodinamska terapija danjim svjetlom provedena je vani u neprekidnom trajanju od 2 sata pod punim danjim svjetlom.
English: Treated lesions that have not completely resolved after 3 months shall be retreated.
Croatian: Liječene lezije koje se nisu potpuno povukle nakon 3 mjeseca potrebno je ponovno liječiti.
English: All patients had 1 to 3 BCC lesions on the face/forehead, bald scalp, extremities and/or neck/trunk.
Croatian: Svi su bolesnici imali 1 do 3 lezije bazocelularnog karcinoma na licu/čelu, vlasištu bez kose, udovima i/ili vratu/trupu.
English: Ameluz is for cutaneous use.
Croatian: Ameluz je namijenjen za kutanu primjenu.
English: Do not use sunscreen with physical filters such as titanium dioxide, zinc oxide, as these inhibit light absorption and may therefore impact efficacy.
Croatian: Ne koristite preparate za zaštitu od sunca s fizikalnim filtrima poput titanijevog dioksida, cinkovog oksida itd., jer inhibiraju apsorpciju svjetla pa stoga mogu utjecati na djelotvornost.
English: Clearance rates and tolerability were dependent on the illumination source.
Croatian: Stope uklanjanja lezija i podnošljivost ovisile su o izvoru osvjetljenja.
English: In a phase II clinical trial, 5-aminolaevulinic acid and protoporphyrin IX serum levels and ALA urine levels were measured before, 3 and 24 hours after administration of Ameluz for photodynamic treatment.
Croatian: U fazi II kliničkog ispitivanja, izmjerene su razine 5-aminolevulinatne kiseline i protoporfirina IX u serumu i ALA u urinu prije, 3 sata poslije i 24 sata poslije primjene lijeka Ameluz u fotodinamskom liječenju.
English: In vitro dermal absorption into human skin was studied using Ameluz containing radiolabelled 5-aminolaevulinic acid (ALA).
Croatian: Apsorpcija In vitro dermalna apsorpcija u ljudsku kožu ispitivana je s lijekom Ameluz koji je sadržavao radiooznačenu 5-aminolevulinatnu kiselinu (ALA).
English: • The active substance is 5-aminolaevulinic acid.
Croatian: • Djelatna tvar je 5-aminolevulinatna kiselina.
English: Treatment of superficial and/or nodular basal cell carcinoma unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome in adults.
Croatian: Liječenje površinskog i/ili nodularnog bazocelularnog karcinoma nepogodnog za kirurško liječenje zbog mogućeg morbiditeta povezanog s liječenjem i/ili lošeg kozmetičkog ishoda u odraslih.
English: Recurrence rates after 12 months were slightly better for Ameluz (41.6%, [95%-confidence interval: 34.4; 49.1]) as compared to MAL (44.8%, [95%-confidence interval: 36.8; 53.0]) and dependent on the light spectrum used for illumination, in favour of narrow spectrum lamps.
Croatian: Stope ponovnog javljanja nakon 12 mjeseci bile su malo bolje s lijekom Ameluz (41,6%), [95%-tni interval pouzdanosti: 34,4; 49,1]) u usporedbi s MAL (44,8%, [95%-tni interval pouzdanosti: 36,8; 53,0]) i ovisni o svjetlosnom spektru osvjetljenja, pri čemu su lampe s uskim spektrom dale bolji rezultat.
English: Illumination using daylight for actinic keratosis treatment If weather conditions are suitable (please see above; Considerations before treatment), you should go outside within 30 minutes after application of the gel and stay for 2 continuous hours in full daylight.
Croatian: Osvjetljavanje danjim svjetlom za liječenje aktiničke keratoze Ako su uvjeti pogodni (pogledajte gore: Uvjeti koje treba uzeti u obzir prije liječenja), trebate izaći van unutar 30 minuta od nanošenja gela i ostati vani neprekidno 2 sata pod punim danjim svjetlom.
English: For treatment of basal cell carcinoma (BCC), two sessions of photodynamic therapy with red-light lamp shall be administered for one or multiple lesions with an interval of about one week between sessions.
Croatian: Za liječenje bazocelularnog karcinoma (BCC), na jednu ili više lezija fotodinamska terapija pomoću izvora crvene svjetlosti primjenjuje se dva puta u vremenskom razmaku od približno jednog tjedna između terapija.
English: The illumination source for PDT treatment of actinic keratoses lesions or fields can be daylight or a red-light lamp.
Croatian: Izvor osvjetljenja u fotodinamskoj terapiji za liječenje lezija ili područja aktiničkih keratoza može biti danje svjetlo ili lampa s crvenom svjetlošću.
English: Treatment of lesions or fields of actinic keratoses and basal cell carcinoma using a red-light lamp
Croatian: Liječenje lezija ili područja aktiničkih keratoza i bazocelularnog karcinoma pomoću lampe s crvenom svjetlošću
English: In case of accidental contact, rinsing with water is recommended.
Croatian: U slučaju nehotičnog kontakta, preporučuje se isprati vodom.
English: Discard open tubes 12 weeks after opening.
Croatian: Otvorenu tubu bacite 12 tjedana nakon otvaranja.
English: The probability of patients in the Ameluz group to require only 1 treatment and remain completely cleared 12 months after the photodynamic therapy was 32.3%, that of patients in the MAL group 22.4% on average with all lamps.
Croatian: Vjerojatnost da bolesnici u skupini s lijekom Ameluz trebaju samo 1 liječenje i budu potpuno očišćeni 12 mjeseci nakon fotodinamskog liječenja bila je 32,3%, kod bolesnika u skupini s MAL 22,4% u prosjeku sa svim lampama.
English: The cosmetic outcome was assessed as very good or good in 47.6% of the subjects in the Ameluz group compared to 25.0% of subjects in the placebo group.
Croatian: Postignut kozmetički ishod bio je procijenjen kao vrlo dobar ili dobar u 47,6% ispitanika skupine s lijekom Ameluz u usporedbi s 25,0% ispitanika skupine s placebom.
English: Only use sunscreen with chemical filters and sun protection factor 30 or higher.
Croatian: Koristite samo preparate za zaštitu od sunca s kemijskim filtrima i faktorom SPF 30 ili višim.
English: • wound secretion
Croatian: • sekrecija rane
English: 5-aminolaevulinic acid
Croatian: 5-aminolevulinatna kiselina
English: Following topical application of 5-aminolaevulinic acid (ALA), the substance is metabolized to protoporphyrin IX, a photoactive compound which accumulates intracellularly in the treated actinic keratosis and basal cell carcinoma lesions.
Croatian: Nakon topikalne primjene 5-aminolevulinatne kiseline (ALA), djelatna tvar se metabolizira u protoporfirin IX, fotoaktivni spoj koji se akumulira u stanicama liječenih lezija aktiničke keratoze i bazocelularnog karcinoma.
English: After application, the active substance of Ameluz becomes a photoactive substance which accumulates in affected cells.
Croatian: Nakon primjene, djelatna tvar lijeka Ameluz postaje fotoaktivna tvar koja se nakuplja u zahvaćenim stanicama.
English: The use of Ameluz requires specific knowledge in photodynamic therapy as it may necessitate the use of a red-light lamp.
Croatian: Osvjetljavanje pomoću lampe s crvenom svjetlošću Primjena Ameluza zahtijeva specifično znanje iz fotodinamske terapije, jer će se možda morati primijeniti lampa s crvenom svjetlošću.
English: • temporary memory loss1
Croatian: • prolazni gubitak pamćenja1
English: Ameluz was superior to placebo with respect to patient complete clearance rates (90.9% vs. 21.9% for Ameluz and placebo, respectively; p < 0.0001) and lesion complete clearance rates (94.3% vs. 32.9%, respectively; p < 0.0001), as controlled 12 weeks after the last PDT.
Croatian: Ameluz je bio superioran placebu s obzirom na stope potpunog uklanjanja lezija kod bolesnika (90,9% za Ameluz i 21,9% za placebo; p< 0,0001) i stope potpuno uklonjenih lezija (94,3% naspram 32,9%; p< 0,0001) prema kontrolnom nalazu 12 tjedana nakon zadnje fotodinamske terapije.
English: Special care should be taken to avoid applying Ameluz into eyes or to mucous membranes.
Croatian: Potreban je poseban oprez kako bi se izbjeglo nanošenje lijeka Ameluz u oči ili na sluznice.
English: Moderate/ severe Scarring None Mild
Croatian: Umjereno/ teško Atrofija Nema Blago
English: • eyelid swelling caused by excess fluid, blurred vision or visual impairment
Croatian: • oticanje kapaka uzrokovano prekomjernim nakupljanjem tekućine, zamagljen vid ili oštećenje vida
English: In a randomised, observer blinded clinical trial with 571 AK patients and a follow-up duration of 6 and 12 months, photodynamic therapy with Ameluz was tested for non-inferiority to a commercially registered cream containing 16% methyl-aminolevulinate (MAL, methyl-[5-amino-4-oxopentanoate]) and superiority over placebo.
Croatian: U randomiziranom kliničkom ispitivanju slijepom za ispitivača s 571 bolesnikom s aktiničkom keratozom i u daljnjem praćenju od 6 i 12 mjeseci, fotodinamska terapija uz Ameluz je ispitana na neinferiornost s registriranom kremom koja sadrži 16% metil-aminolevulinata (MAL, metil-[5-amino4-oksopentanoat]) i superiornost placebu.
English: Keep this medicine out of the sight and reach of children.
Croatian: Kako čuvati Ameluz Lijek čuvajte izvan pogleda i dohvata djece.
English: MAL Patient number n (%)
Croatian: MAL Broj bolesnika n (%)
English: • reactions at the application site
Croatian: • reakcije na mjestu nanošenja
English: Total lesion clearance rates were higher for Ameluz (90.4%) compared to MAL (83.2%) and placebo (37.1%).
Croatian: Ukupna stopa uklanjanja lezija bila je viša za Ameluz (90,4%) u usporedbi sa MAL (83,2%) i placebo (37,1%).
English: In rare cases, interruption or discontinuation of illumination may be necessary.
Croatian: rijetkim slučajevima može biti potrebno privremeno ili potpuno prekinuti osvjetljavanje.
English: At application site: Vesicles, discharge, erosion, reaction, discomfort, hyperalgesia, haemorrhage, warmth
Croatian: Na mjestu primjene: vezikule, iscjedak, erozija, reakcija, nelagoda, hiperalgezija, krvarenje, toplina
English: • Lesions and fields of actinic keratoses are treated with one session.
Croatian: • Lezije i područja aktiničke keratoze liječe se u jednom tretmanu.
English: Risk of mucous membrane and eye irritation
Croatian: Rizik od nadraženosti sluznica i oka
English: A maximal use PK study was conducted in 12 patients bearing at least 10 mild to moderate AKs on the face or forehead.
Croatian: Farmakokinetičko ispitivanje maksimalne primjene provedeno je u 12 bolesnika s najmanje 10 blagih do umjerenih lezija aktiničke keratoze na licu ili čelu.
English: The following table presents the efficacy and the adverse reactions transient pain and erythema occurring at the application site during photodynamic therapy with different light sources:
Croatian: Sljedeća tablica prikazuje djelotvornost i nuspojave prolazne boli i eritema koji su se javljali na mjestu primjene tijekom fotodinamskog liječenja s različitim izvorima svjetlosti:
English: • superficial and/or nodular basal cell carcinoma unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome in adults.
Croatian: • liječenje površinskog i/ili nodularnog bazocelularnog karcinoma nepogodnog za kirurško liječenje zbog mogućeg morbiditeta povezanog s liječenjem i/ili lošeg kozmetičkog ishoda u odraslih.
English: • sodium benzoate: Mildly irritant to the skin, eyes and mucous membranes.
Croatian: • natrijev benzoat: Blago nadražujući za kožu, oči i sluznice.
English: Unopened tube: 18 months After first opening: 12 weeks
Croatian: 6.3 Rok valjanosti Neotvorena tuba: 18 mjeseci
English: Each carton contains one aluminium tube with 2 g gel closed with a polyethylene screw cap.
Croatian: Jedna kutija sadrži jednu aluminijsku tubu s 2 g gela zatvorenu navojnim čepom od polietilena.
English: The percentage of patients with skin impairment before PDT and 12 months after PDT is listed in the table below.
Croatian: Postotak bolesnika s oštećenjem kože prije fotodinamske terapije i 12 mjeseci poslije fotodinamske terapije naveden je u tablici niže.